Author Profile

Gary Bridgman

Gary Bridgman
Gary Bridgman is an enterprise content specialist in the Communications Department at St. Jude Children’s Research Hospital.

Stories by Gary Bridgman

Staff scientists in core research facilities accelerate and broaden biomedical discovery
Staff scientists in core research facilities accelerate and broaden biomedical discovery
Research

Staff scientists in core research facilities accelerate and broaden biomedical discovery

Gary Bridgman

These labs are highly specialized and deliver researchers access to advanced and speedy scientific results.

Music therapy program goes digital to reach quarantined patients
Music therapy program goes digital to reach quarantined patients
Clinical

Music therapy program goes digital to reach quarantined patients

Gary Bridgman

Read how this music therapist continues to help pediatric cancer patients with music therapy sessions even during quarantine.

Ilaria Iacobucci Research Staff of the Year
Ilaria Iacobucci Research Staff of the Year
Investigator Insights

Research Staff of the Year honoree Ilaria Iacobucci loves her work more than she misses Italy

Gary Bridgman

Staff scientist in Charles Mullighan’s pathology lab praised for new experimental approaches to leukemia pathogenesis and for helping others.

Patenting ideas from bench to bedside
Patenting ideas from bench to bedside
Outreach

The agents of discovery: patenting and licensing ideas from bench to bedside

Gary Bridgman

Meet St. Jude’s tech transfer experts who patent and license researchers’ basic science discoveries to help patients worldwide.

First Year of WHO Global Initiative for Childhood Cancer
First Year of WHO Global Initiative for Childhood Cancer
Outreach

Memphis to Myanmar: A Year in the life of the Global Initiative for Childhood Cancer

Gary Bridgman

Catherine Lam, MD, of St. Jude Global, has traveled around world to help low- and middle income countries improve children’s access to cancer care.

SJELIOT clinical trial of children’s brain tumor therapy
SJELIOT clinical trial of children’s brain tumor therapy
Research

SJELIOT clinical trial explores a new approach for recurring and unresponsive medulloblastoma tumors

Gary Bridgman

St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.

Bioinformatics research scientist helps unlock elusive data
Bioinformatics research scientist helps unlock elusive data
Research

From evolutionary biology to immunology via bioinformatics

Gary Bridgman

Immunologists turn to Jeremy Crawford, PhD, when planning complex experiments or re-analyzing collected data. Learn about his bioinformatics career.